Hydrocodone Not Working? Why Norco or Vicodin May Not Relieve Your Pain

Tolerance and physical dependence can develop during opioid treatment, so a dose that worked at first can feel weaker after regular use.^[3] This is one of the most common reasons hydrocodone seems to stop working. It is not something to solve by taking more on your own; tell your prescriber how your pain and relief have changed over time.

Immediate-release hydrocodone has a half-life of about 3.8 hours,^[3] so relief can fade before the next dose is due. Your prescriber can judge whether the dose, the timing, or a different treatment fits your pain better. Keep a short log of when you take each dose and when the pain returns.

In Norco, Vicodin, and Lortab, the hydrocodone comes with acetaminophen. The label caps the daily number of tablets, and acetaminophen has caused acute liver failure, mostly at doses above 4,000 mg a day and often when more than one acetaminophen product was taken.^[3] Check other medicines you take, including over-the-counter cold and pain products, for acetaminophen or APAP on the label, and do not add extra Tylenol without asking.

CYP3A4 does most of the work of clearing hydrocodone. Starting a CYP3A4 inducer, such as rifampin, carbamazepine, or phenytoin, can lower hydrocodone levels and reduce pain relief, and in someone physically dependent it can bring on withdrawal.^[3] The opposite is dangerous: CYP3A4 inhibitors, or stopping an inducer, can raise hydrocodone levels and cause fatal breathing problems. In one study, the antifungal ketoconazole raised hydrocodone exposure by 135%.^[4] Give your prescriber and pharmacist a full list of what you take.

Hydrocodone is meant for pain severe enough to need an opioid.^[3] Nerve pain, inflammatory pain, and many chronic pain conditions often respond poorly to opioids, and a different kind of treatment may fit better. Less often, opioids can cause opioid-induced hyperalgesia, in which the medicine itself makes pain worse; the label describes it, and it is worth raising if your pain is spreading or getting worse as treatment goes on.^[3]

People with little or no CYP2D6 activity make less hydromorphone from hydrocodone. It is not clear that this reduces pain relief, so CPIC still recommends usual label dosing for these people, with a different opioid to consider if hydrocodone does not help.^[1] The next section explains what that means.

Codeine and tramadol are prodrugs: they relieve little pain until CYP2D6 converts them. Hydrocodone is different. It is an active opioid, and CYP2D6 converts only a small share of it to hydromorphone, so the gene matters less.^[2]

The 2021 CPIC opioid guideline gives this advice for hydrocodone:^[1]

• Normal metabolizers: use the usual label dosing (strong recommendation).
• Intermediate and poor metabolizers: use the usual label dosing. If there is no response and an opioid is still needed, consider one other than codeine or tramadol (optional recommendation, meaning the evidence is weak).
• Ultrarapid metabolizers: no recommendation, because there is minimal evidence about side effects or pain relief.

CPIC adds that it is not known whether a higher hydrocodone dose would help intermediate or poor metabolizers.^[2] It names codeine and tramadol as opioids to pass over because both depend on CYP2D6 for much of their effect.

A low CYP2D6 result does not make hydrocodone safer either. Most of it is still cleared by CYP3A4, so the interaction warnings above apply to everyone.^[4]

A CYP2D6 result is most useful when hydrocodone, codeine, or tramadol have all done little for your pain, or when you want to know before a planned surgery or dental procedure which opioids are likely to work. For codeine and tramadol, a poor metabolizer result is a strong reason to avoid them.^[1] For hydrocodone it is weaker: it supports the conversation about an alternative if hydrocodone fails, rather than predicting that it will.

Hydrocodone is included in the Gene2Rx Full Report ($50); it is not part of the Starter or Psychiatric reports. A few limits to know:

• Consumer DNA tests such as 23andMe and AncestryDNA are not clinical-grade tests, and their raw data is labeled not for medical use.
• Genetics is one factor. Tolerance, dose, the type of pain, and other medicines often matter more for hydrocodone.

Norco is hydrocodone with acetaminophen, so the reasons are the same as for hydrocodone: tolerance after regular use, a dose or schedule that does not match your pain, a type of pain that responds poorly to opioids, or another medicine that speeds up hydrocodone's clearance through CYP3A4.^[3] CYP2D6 genetics may play a smaller part. Talk to your prescriber rather than taking more tablets, because the acetaminophen limits how much is safe.

They work differently. Hydrocodone is a full opioid that acts on its own.^[3] Tramadol is a weaker opioid whose opioid effect depends on CYP2D6 converting it, so for poor metabolizers it may give little opioid relief.^[1] Which one is right, and at what dose, depends on your pain and your health, so the comparison is a question for your prescriber.

It may. Codeine and tramadol fail in CYP2D6 poor metabolizers because they need that enzyme to be activated. Hydrocodone is active on its own, and CPIC advises usual label dosing for poor metabolizers rather than avoiding it.^[1] Studies disagree on whether poor metabolizers get less relief from hydrocodone.

CPIC states that it is not known whether increasing the hydrocodone dose would improve pain relief in intermediate or poor metabolizers.^[2] Its advice is to consider a different opioid, other than codeine or tramadol, if hydrocodone does not help. Do not change your dose without your prescriber.

Yes. Medicines that speed up CYP3A4, such as rifampin, carbamazepine, and phenytoin, can lower hydrocodone levels and reduce pain relief.^[3] Medicines that block CYP3A4 do the opposite and can raise levels to dangerous ones. Strong CYP2D6 blockers reduce hydromorphone, with the same uncertain effect as a poor metabolizer result.